ARISTADA®

(aripiprazole lauroxil)

Prescribing Information Medication Guide
ARISTADA INITIO®

(aripiprazole lauroxil)

Prescribing Information Medication Guide
Publications

Alkermes Sponsored Phase 3 Clinical Trials

Aug 2015
A randomized, double-blind, placebo-controlled trial of aripiprazole lauroxil in acute exacerbation of schizophrenia
The Journal of Clinical Psychiatry
AUTHOR(S)

Meltzer HY, Risinger R, Nasrallah HA, Du Y, Zummo J, Corey L, Bose A, Stankovic S, Silverman BL, Ehrich EW.

View on PubMed
Aug 2019
Long-term safety and tolerability of aripiprazole lauroxil in patients with schizophrenia
CNS Spectrums
AUTHOR(S)

Nasrallah HA, Aquila R, Du Y, Stanford AD, Claxton A, Weiden PJ.

View on PubMed
May 2020
Efficacy and Safety of a 2-Month Formulation of Aripiprazole Lauroxil With 1-Day Initiation in Patients Hospitalized for Acute Schizophrenia Transitioned to Outpatient Care: Phase 3, Randomized, Double-Blind, Active-Control ALPINE Study
The Journal of Clinical Psychiatry
AUTHOR(S)

Weiden PJ, Claxton A, Kunovac J, Walling DP, Du Y, Yao B, Yagoda S, Bidollari I, Keane E, Cash E.

View on PubMed